Renovaro Biosciences (RENB) went public on February 2, 2015, when it opened at a split-adjusted price of $60.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
October 2025 | $1.55 | $1.55 | $1.12 | $1.13 | 2,583,255 |
September 2025 | $2.45 | $2.45 | $1.21 | $1.27 | 8,304,650 |
August 2025 | $2.70 | $2.70 | $2.20 | $2.38 | 1,739,832 |
July 2025 | $2.90 | $3.60 | $2.55 | $2.56 | 2,973,450 |
June 2025 | $3.10 | $4.50 | $2.70 | $2.89 | 16,467,771 |
May 2025 | $3.60 | $5.50 | $2.76 | $3.10 | 3,309,375 |
April 2025 | $5.44 | $5.51 | $3.05 | $3.60 | 1,731,870 |
March 2025 | $10.20 | $10.30 | $5.43 | $5.43 | 1,198,474 |
February 2025 | $7.50 | $14.00 | $6.70 | $9.83 | 4,420,042 |
January 2025 | $8.70 | $12.80 | $7.00 | $7.50 | 2,759,762 |
December 2024 | $7.70 | $21.00 | $6.70 | $8.36 | 3,485,725 |
November 2024 | $5.16 | $8.32 | $4.60 | $7.56 | 704,530 |
October 2024 | $4.83 | $10.10 | $3.95 | $5.32 | 1,633,351 |
September 2024 | $6.00 | $7.68 | $4.51 | $4.83 | 826,762 |
August 2024 | $8.39 | $8.48 | $4.20 | $5.99 | 872,272 |
July 2024 | $17.00 | $17.40 | $6.46 | $7.30 | 1,572,460 |
June 2024 | $14.90 | $23.40 | $12.60 | $17.50 | 3,046,394 |
May 2024 | $15.10 | $17.50 | $8.20 | $14.90 | 1,202,616 |
April 2024 | $26.60 | $30.50 | $12.40 | $15.80 | 636,859 |
March 2024 | $25.00 | $33.80 | $22.00 | $26.50 | 955,317 |
February 2024 | $43.10 | $44.50 | $16.20 | $25.80 | 554,186 |
January 2024 | $31.50 | $52.50 | $29.90 | $43.70 | 344,149 |
December 2023 | $33.10 | $38.60 | $28.20 | $31.70 | 155,065 |
November 2023 | $29.00 | $35.95 | $25.90 | $33.30 | 192,937 |
October 2023 | $45.40 | $52.50 | $24.00 | $28.40 | 497,506 |
